Deirdre Renee Claytor

Array ( [id] => 196840 [patent_doc_number] => 07638507 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-29 [patent_title] => 'Compositions for treatment of inflammatory diseases' [patent_app_type] => utility [patent_app_number] => 11/347148 [patent_app_country] => US [patent_app_date] => 2006-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9070 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/638/07638507.pdf [firstpage_image] =>[orig_patent_app_number] => 11347148 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5074758 [patent_doc_number] => 20070014733 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-18 [patent_title] => 'Hydroxylated nebivolol metabolites' [patent_app_type] => utility [patent_app_number] => 11/342497 [patent_app_country] => US [patent_app_date] => 2006-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 27086 [patent_no_of_claims] => 82 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20070014733.pdf [firstpage_image] =>[orig_patent_app_number] => 11342497 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5875487 [patent_doc_number] => 20060167068 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Method of treating self-injurious behavior with glutamate modulating agents' [patent_app_type] => utility [patent_app_number] => 11/339881 [patent_app_country] => US [patent_app_date] => 2006-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6042 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20060167068.pdf [firstpage_image] =>[orig_patent_app_number] => 11339881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5694761 [patent_doc_number] => 20060154908 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => 'Co-administration of dehydroepiandrosterone (DHEA) congeners and other active agents for treating depression' [patent_app_type] => utility [patent_app_number] => 11/342276 [patent_app_country] => US [patent_app_date] => 2006-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8249 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0154/20060154908.pdf [firstpage_image] =>[orig_patent_app_number] => 11342276 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5683592 [patent_doc_number] => 20060199862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-07 [patent_title] => 'Method for enhancing cognitive function' [patent_app_type] => utility [patent_app_number] => 11/338169 [patent_app_country] => US [patent_app_date] => 2006-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1662 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20060199862.pdf [firstpage_image] =>[orig_patent_app_number] => 11338169 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5160419 [patent_doc_number] => 20070173463 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-26 [patent_title] => 'Method and composition for treating otitis media' [patent_app_type] => utility [patent_app_number] => 11/336325 [patent_app_country] => US [patent_app_date] => 2006-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1800 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20070173463.pdf [firstpage_image] =>[orig_patent_app_number] => 11336325 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5786755 [patent_doc_number] => 20060205753 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'Use of methylnaltrexone and related compounds to treat post-operative gastrointestinal dysfunction' [patent_app_type] => utility [patent_app_number] => 11/336418 [patent_app_country] => US [patent_app_date] => 2006-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11917 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0205/20060205753.pdf [firstpage_image] =>[orig_patent_app_number] => 11336418 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5677347 [patent_doc_number] => 20060182702 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-17 [patent_title] => 'Composition containing a cation, a cationic polymer, a solid compound and a starch, and cosmetic treatment process' [patent_app_type] => utility [patent_app_number] => 11/334473 [patent_app_country] => US [patent_app_date] => 2006-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8866 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20060182702.pdf [firstpage_image] =>[orig_patent_app_number] => 11334473 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4524562 [patent_doc_number] => 07951831 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-31 [patent_title] => 'Use of inhibitors of soluble epoxide hydrolase to synergize activity of COX and 5-LOX inhibitors' [patent_app_type] => utility [patent_app_number] => 11/330033 [patent_app_country] => US [patent_app_date] => 2006-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 19316 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/951/07951831.pdf [firstpage_image] =>[orig_patent_app_number] => 11330033 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5596871 [patent_doc_number] => 20060160789 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Use of pharmacological compounds for the prevention or treatment of acute tolerance to morphines' [patent_app_type] => utility [patent_app_number] => 11/320735 [patent_app_country] => US [patent_app_date] => 2005-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3899 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20060160789.pdf [firstpage_image] =>[orig_patent_app_number] => 11320735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5656568 [patent_doc_number] => 20060142304 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Method for treating or preventing pruritic and neurogenic skin disorders' [patent_app_type] => utility [patent_app_number] => 11/315773 [patent_app_country] => US [patent_app_date] => 2005-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3310 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20060142304.pdf [firstpage_image] =>[orig_patent_app_number] => 11315773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5694792 [patent_doc_number] => 20060154939 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => 'Medicaments for the Treatment or Prevention of Fibrotic Diseases' [patent_app_type] => utility [patent_app_number] => 11/275225 [patent_app_country] => US [patent_app_date] => 2005-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13534 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0154/20060154939.pdf [firstpage_image] =>[orig_patent_app_number] => 11275225 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5656537 [patent_doc_number] => 20060142273 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Use of selected CGRP-antagonists in combination with other antimigraine drugs for the treatment of migraine' [patent_app_type] => utility [patent_app_number] => 11/275169 [patent_app_country] => US [patent_app_date] => 2005-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11797 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20060142273.pdf [firstpage_image] =>[orig_patent_app_number] => 11275169 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5120681 [patent_doc_number] => 20070142396 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'Treatment of pain with 1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2(1H)-quinolone or salt thereof' [patent_app_type] => utility [patent_app_number] => 11/305593 [patent_app_country] => US [patent_app_date] => 2005-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 8920 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20070142396.pdf [firstpage_image] =>[orig_patent_app_number] => 11305593 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9216000 [patent_doc_number] => 08628796 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-14 [patent_title] => 'Room-temperature stable dronabinol formulations' [patent_app_type] => utility [patent_app_number] => 11/299183 [patent_app_country] => US [patent_app_date] => 2005-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 65615 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11299183 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5656552 [patent_doc_number] => 20060142288 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Combinations and methods for headaches' [patent_app_type] => utility [patent_app_number] => 11/294345 [patent_app_country] => US [patent_app_date] => 2005-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4521 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20060142288.pdf [firstpage_image] =>[orig_patent_app_number] => 11294345 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5667724 [patent_doc_number] => 20060173074 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-03 [patent_title] => 'Treatment of restless legs syndrome' [patent_app_type] => utility [patent_app_number] => 11/269547 [patent_app_country] => US [patent_app_date] => 2005-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2614 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20060173074.pdf [firstpage_image] =>[orig_patent_app_number] => 11269547 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5046601 [patent_doc_number] => 20070265275 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-15 [patent_title] => 'Treatment of Mastitis' [patent_app_type] => utility [patent_app_number] => 11/718999 [patent_app_country] => US [patent_app_date] => 2005-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1991 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20070265275.pdf [firstpage_image] =>[orig_patent_app_number] => 11718999 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5913611 [patent_doc_number] => 20060128673 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-15 [patent_title] => 'Pharmaceutical compositions comprising CB1 cannabinoid receptor antagonists and potassium channel openers for the treatment of obesity and related conditions' [patent_app_type] => utility [patent_app_number] => 11/257056 [patent_app_country] => US [patent_app_date] => 2005-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13698 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20060128673.pdf [firstpage_image] =>[orig_patent_app_number] => 11257056 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 123311 [patent_doc_number] => 07705054 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-04-27 [patent_title] => 'Method of preventing and/or treating oxidant injury in neurodegenerative and oxidative diseases' [patent_app_type] => utility [patent_app_number] => 11/254846 [patent_app_country] => US [patent_app_date] => 2005-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 41 [patent_no_of_words] => 27797 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/705/07705054.pdf [firstpage_image] =>[orig_patent_app_number] => 11254846 [rel_patent_id] =>[rel_patent_doc_number] =>)